CARISMA Therapeutics Inc (CARM)
1.03
-0.11
(-9.65%)
USD |
NASDAQ |
Jun 17, 16:00
1.02
-0.01
(-0.97%)
Pre-Market: 20:00
CARISMA Therapeutics Price to Book Value: 3.927 for June 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| June 17, 2024 | 3.927 |
| June 14, 2024 | 4.347 |
| June 13, 2024 | 4.461 |
| June 12, 2024 | 4.461 |
| June 11, 2024 | 4.728 |
| June 10, 2024 | 5.071 |
| June 07, 2024 | 4.118 |
| June 06, 2024 | 4.232 |
| June 05, 2024 | 4.385 |
| June 04, 2024 | 4.538 |
| June 03, 2024 | 4.957 |
| May 31, 2024 | 5.071 |
| May 30, 2024 | 4.995 |
| May 29, 2024 | 4.919 |
| May 28, 2024 | 5.109 |
| May 24, 2024 | 5.148 |
| May 23, 2024 | 4.804 |
| May 22, 2024 | 5.376 |
| May 21, 2024 | 5.414 |
| May 20, 2024 | 5.376 |
| May 17, 2024 | 5.376 |
| May 16, 2024 | 5.224 |
| May 15, 2024 | 5.338 |
| May 14, 2024 | 5.567 |
| May 13, 2024 | 5.643 |
| Date | Value |
|---|---|
| May 10, 2024 | 5.643 |
| May 09, 2024 | 5.758 |
| May 08, 2024 | 5.910 |
| May 07, 2024 | 5.910 |
| May 06, 2024 | 6.082 |
| May 03, 2024 | 6.177 |
| May 02, 2024 | 6.101 |
| May 01, 2024 | 6.215 |
| April 30, 2024 | 6.215 |
| April 29, 2024 | 6.368 |
| April 26, 2024 | 6.253 |
| April 25, 2024 | 6.253 |
| April 24, 2024 | 6.406 |
| April 23, 2024 | 6.482 |
| April 22, 2024 | 7.130 |
| April 19, 2024 | 6.215 |
| April 18, 2024 | 6.520 |
| April 17, 2024 | 6.444 |
| April 16, 2024 | 6.482 |
| April 15, 2024 | 6.711 |
| April 12, 2024 | 7.359 |
| April 11, 2024 | 7.550 |
| April 10, 2024 | 7.283 |
| April 09, 2024 | 7.550 |
| April 08, 2024 | 7.664 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.319
Minimum
Apr 10 2023
7.969
Maximum
Apr 01 2024
3.647
Average
3.461
Median
Jun 15 2023
Price to Book Value Benchmarks
| Verastem Inc | 3.506 |
| Aquestive Therapeutics Inc | -- |
| Gritstone Bio Inc | 5.915 |
| Black Diamond Therapeutics Inc | 2.951 |
| Moderna Inc | 4.123 |
Price to Book Value Related Metrics
| PS Ratio | 2.767 |
| Price | 1.03 |
| Earnings Yield | -190.3% |
| Market Cap | 42.79M |